Document is current
Any future updates will be listed below
-
Authors
Bazzi, Angela R.
Valasek, Chad J.
Stamos-Buesig, Tara
Eger, William H.
Harvey-Vera, Alicia
Vera, Carlos F.
Syvertsen, Jennifer L.
Storholm, Erik D.
Bartholomew, Tyler S.
Tookes, Hansel E.
Strathdee, Steffanie A.
Pines, Heather A.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (P30AI036214, P30AI036214, P30AI036214, P30AI036214)
National Institute on Drug Abuse (R34DA058389, T32DA023356, T32DA023356, R01DA049644, R01DA049644, R34DA058389, R34DA058389, DP2DA053720, DP2DA053720, R01DA049644, R34DA058389)
- License Information
-
More Information
Article History
Received: 10 October 2023
Accepted: 26 January 2024
First Online: 4 February 2024
Declarations
:
: Participants provided verbal informed consent to participate in this study. The institutional review board of the University of California, San Diego reviewed and approved all study procedures and granted a waiver of documentation of consent.
: Participants provided consent to have de-identified information about themselves published.
: Drs. Tookes and Bartholomew report receiving research funding from Gilead Sciences and Viiv Healthcare. All other authors report no conflicts of interest to declare.
